Intracranial efficacy and safety of furmonertinib 160 mg with or without anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy

OBJECTIVES: Central nervous system (CNS) metastases including brain metastases (BM) and leptomeningeal metastases (LM) are frequent in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), and are correlated with poor outcomes. In this study, we evaluated the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ziyi, Hao, Xuezhi, Wang, Qi, Yang, Ke, Li, Junling, Xing, Puyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985196/
https://www.ncbi.nlm.nih.gov/pubmed/36870951
http://dx.doi.org/10.1186/s12885-023-10676-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985196/
https://www.ncbi.nlm.nih.gov/pubmed/36870951
http://dx.doi.org/10.1186/s12885-023-10676-x

Ejemplares similares